Human Immunodeficiency Virus 1 (HIV 1) Chimeric Ag >90%

Manufactured for life-science research workflows, this recombinant antigen from Antibodies.com targets the Human Immunodeficiency Virus Type 1 (HIV-1) and is supplied as a 1 mg liquid preparation in Tris-HCl buffer (pH 8.5) supplemented with EDTA. The chimeric immunogen is expressed in an E. coli host and purified to greater than 90% purity, with specificity directed against the gp120 and gp41 envelope regions commonly used to detect anti-HIV antibodies. The preparation is validated for lateral flow assay (LFA) development, making it suitable as an immobilized capture or detector reagent in rapid immunochromatographic test strips, as well as for use in ELISA and Western blot workflows during assay optimization. Each lot is shipped at 2–8 °C and should be stored under the same refrigerated conditions to preserve activity; the material is intended for research use only and is not cleared for diagnostic or in vivo applications. Reactivity is restricted to HIV-1, and because the antigen is a recombinant E. coli-derived protein, it is not a monoclonal or polyclonal antibody and therefore carries no host isotype, clonality, or conjugate label. Researchers building serological detection assays, calibration standards, or internal process controls will find this >90% pure chimeric antigen a consistent building block from the Antibodies.com antigens catalogue, and the 1 mg pack size provides ample material for both feasibility studies and small-batch assay production runs.